CoChat

Progress of exosomes in the diagnosis and treatment of lung cancer

Open access
Xu, Kanghong, Zhang, Chengpeng, Du, Tiantian, Gabriel, Abakundana Nsenga Ariston, Wang, Xue, Li, Xiaomeng, Sun, Li, Wang, Nan, Jiang, Xinquan, Zhang, Yi · 2021 · Biomedicine & Pharmacotherapy
Cited by 177

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

The incidence and mortality of lung cancer account for first place all over the world. Lung cancer lacks early diagnostic biomarkers; lung cancer patients are usually diagnosed in both middle and advanced stages and have poor treatment outcomes. It is more important to find the first diagnostic tools for lung cancer with high specificity and sensitivity. Besides, exosomes are usually nanometer-sized bi-layered lipid vesicles formed and produced by various types of cells. As one of the main modes of intercellular communication, they can deliver multiple functional biomolecules, such as DNA, microRNAs, messenger RNA (mRNA), long non-coding RNA, and proteins, and the events as mentioned above affects different physiological processes of recipient cells. It has been reported that exosomes are involved in different types of cancer, including lung cancer. Various studies proved that exosomes are involved in multiple cancer processes such as cell proliferation, metastasis, epithelial-mesenchymal transition (EMT), angiogenesis, and the tumor microenvironment in lung cancer. Tumor-derived exosomes (TEX) contain a variety of stimulatory and inhibitory factors involved in regulating immune response, which can affect the tumor microenvironment (TME) and thus participate in the formation and progression of lung cancer. This review's primary purpose to review the latest research progress of exosomes in diagnosing and treating lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2020.111111

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 177

Metadata

Authors
Xu, K., Zhang, C., Du, T., Gabriel, A. N. A., Wang, X., Li, X., Sun, L., Wang, N., Jiang, X., & Zhang, Y.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2021-02
Volume
134
Pages
111111
ISSN
0753-3322 (ISSN-L)
OpenAlex
W3115220284
Cited by
177
References
24
FWCI
6.64
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress of exosomes in the diagnosis and treatment of lung cancer. https://app.cochat.ai/papers/10.1016/j.biopha.2020.111111
The paper
Xu, K., Zhang, C., Du, T., Gabriel, A. N. A., Wang, X., Li, X., Sun, L., Wang, N., Jiang, X., & Zhang, Y. (2021). Progress of exosomes in the diagnosis and treatment of lung cancer. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2020.111111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.